Co-Diagnostics Current Ratio 2017-2025 | CODX
Co-Diagnostics current ratio from 2017 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Co-Diagnostics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.01B | $0.00B | 3.81 |
| 2025-06-30 | $0.02B | $0.00B | 4.13 |
| 2025-03-31 | $0.02B | $0.01B | 4.43 |
| 2024-12-31 | $0.03B | $0.01B | 4.41 |
| 2024-09-30 | $0.04B | $0.01B | 6.92 |
| 2024-06-30 | $0.05B | $0.01B | 9.09 |
| 2024-03-31 | $0.05B | $0.01B | 10.19 |
| 2023-12-31 | $0.06B | $0.01B | 10.81 |
| 2023-09-30 | $0.07B | $0.01B | 13.99 |
| 2023-06-30 | $0.08B | $0.01B | 15.13 |
| 2023-03-31 | $0.09B | $0.00B | 23.80 |
| 2022-12-31 | $0.09B | $0.00B | 23.94 |
| 2022-09-30 | $0.10B | $0.01B | 16.95 |
| 2022-06-30 | $0.12B | $0.01B | 17.06 |
| 2022-03-31 | $0.13B | $0.01B | 9.63 |
| 2021-12-31 | $0.12B | $0.01B | 9.14 |
| 2021-09-30 | $0.10B | $0.00B | 24.83 |
| 2021-06-30 | $0.09B | $0.01B | 19.10 |
| 2021-03-31 | $0.08B | $0.00B | 18.38 |
| 2020-12-31 | $0.07B | $0.00B | 16.69 |
| 2020-09-30 | $0.05B | $0.00B | 28.63 |
| 2020-06-30 | $0.04B | $0.00B | 12.36 |
| 2020-03-31 | $0.02B | $0.00B | 16.43 |
| 2019-12-31 | $0.00B | $0.00B | 4.83 |
| 2019-09-30 | $0.00B | $0.00B | 10.02 |
| 2019-06-30 | $0.01B | $0.00B | 14.61 |
| 2019-03-31 | $0.01B | $0.00B | 16.53 |
| 2018-12-31 | $0.00B | $0.00B | 0.45 |
| 2018-09-30 | $0.00B | $0.00B | 1.09 |
| 2018-06-30 | $0.00B | $0.00B | 6.13 |
| 2018-03-31 | $0.00B | $0.00B | 10.98 |
| 2017-12-31 | $0.00B | $0.00B | 7.09 |
| 2017-09-30 | $0.01B | $0.00B | 8.73 |
| 2017-06-30 | $0.00B | $0.01B | 0.07 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.004B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.388B | 30.55 |
| HCA Healthcare (HCA) | United States | $109.378B | 18.11 |
| CVS Health (CVS) | United States | $102.418B | 11.78 |
| Elevance Health (ELV) | United States | $82.379B | 12.08 |
| Cencora (COR) | United States | $67.098B | 21.63 |
| Natera (NTRA) | United States | $32.905B | 0.00 |
| DiDi Global (DIDIY) | China | $23.862B | 22.04 |
| Labcorp Holdings (LH) | United States | $21.055B | 16.05 |
| Medpace Holdings (MEDP) | United States | $17.138B | 42.55 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.432B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Viatris (VTRS) | United States | $15.399B | 5.74 |
| ICON (ICLR) | Ireland | $14.802B | 14.69 |
| Solventum (SOLV) | United States | $13.881B | 13.47 |
| Revvity (RVTY) | United States | $12.487B | 22.99 |
| CochLear (CHEOY) | Australia | $11.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.778B | 20.76 |
| Avantor (AVTR) | United States | $8.591B | 13.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.606B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.449B | 0.00 |
| HealthEquity (HQY) | United States | $7.201B | 26.93 |
| BrightSpring Health Services (BTSG) | United States | $6.965B | 41.53 |
| PACS (PACS) | United States | $6.598B | 40.12 |
| Bausch + Lomb (BLCO) | Canada | $6.181B | 40.58 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.186B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.175B | 55.76 |
| Concentras Parent (CON) | United States | $2.599B | 16.22 |
| Organon (OGN) | United States | $2.192B | 2.31 |
| Progyny (PGNY) | United States | $2.176B | 42.78 |
| Surgery Partners (SGRY) | United States | $2.080B | 26.80 |
| Pediatrix Medical (MD) | United States | $1.904B | 11.37 |
| Establishment Labs Holdings (ESTA) | United States | $1.893B | 0.00 |
| Ardent Health (ARDT) | United States | $1.266B | 4.13 |
| Teladoc Health (TDOC) | United States | $1.241B | 0.00 |
| Nutex Health (NUTX) | United States | $1.221B | 9.33 |
| CareDx (CDNA) | United States | $1.038B | 16.97 |
| GoodRx Holdings (GDRX) | United States | $0.971B | 15.89 |
| Omada Health (OMDA) | United States | $0.934B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.750B | 4.26 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.708B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Enhabit (EHAB) | United States | $0.554B | 24.89 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.466B | 0.00 |
| SBC Medicals (SBC) | United States | $0.457B | 8.42 |
| Agilon Health (AGL) | United States | $0.394B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.349B | 5.62 |
| Oncology Institute (TOI) | United States | $0.347B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.280B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.085B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |